ESAB Corporation (ESAB) | The Buildout — AI Infrastructure

Mkt cap · 52-wk · YTD · delayed
Updated Aug 12, 2026Q1 FY2026 reviewed
ESAB manufactures welding and fabrication equipment, consumables, gas control, robotics, and inspection systems; its precision welding and gas-control products serve semiconductor manufacturing, power generation, and industrial infrastructure.
Q2 organic +2.5%
Both segments returned to core organic growth after Q1's tariff-driven -3% volume.
Equipment >50%
Eddyfi close took pro forma equipment mix past half of revenue.
EBITDA guide raised
FY26 adjusted EBITDA lifted to $615M–$625M with seven months of Eddyfi.
Asbestos overhang
May 28 South Carolina ruling added unquantified veil-piercing liability risk.
The Buildout Takeaway
The equipment mix shift is running ahead of schedule, and the organic demand rebound management telegraphed after Q1 has started to arrive. The unresolved risk sits outside the operational story: a new, still-unquantified asbestos liability from the May South Carolina Supreme Court ruling.
10 analysts·9 Buy1 Hold0 Sell
Coverage is thin — only 3 price estimates, so no target is shown

Total core sales ~$3.0B–$3.1B · organic growth 2%–4% · acquisition contribution ~9 points · adjusted EBITDA $615M–$625M · adjusted EPS $5.40–$5.50 · FCF conversion ~90%
Important: The Buildout is a data analytics platform. Content is generated by algorithms and AI agents using public filings, earnings transcripts, and market data. This is not personalized investment advice.
Our View

The Verdict

ESAB is a global fabrication-technology company. It makes welding and cutting equipment, consumables, gas-control hardware, robotics, and, after the Eddyfi acquisition, inspection and monitoring systems. Its connection to the AI buildout is indirect: precision welding and high-purity gas-control products serve semiconductor manufacturing, while broader fabrication equipment feeds power-generation, grid, defense, and nuclear end markets. Management does not present the company as an AI business.

Market Cap
Revenue (TTM)$2.9B
Revenue Growth+6.6%
EBITDA Margin (TTM)20.1%
Net Debt$1.1B
Earnings Beats6 of 7
P/E (TTM)
EV/EBITDA (TTM)

What We Like

  • Equipment was 38% of sales in 2016 and over 50% of revenue pro forma after Eddyfi, making the mix shift explicit.
  • Gross margin moved from about 35% in 2016 to nearly 38% before Eddyfi; management targets above 40% for 2027 and beyond.
  • Q2 core organic growth came in at +2.5% in both segments after Q1's -3% volume, supporting the H2 volume path.
  • Eddyfi closed ahead of schedule with ~65% gross margins and a ~$450M commercial funnel.
  • EWM and Aktiv are growing double digits, and EWM is expected to become EBITDA accretive in Q4 2026.

What We’re Watching

  • South Carolina asbestos ruling of May 28, 2026 is unquantified, classified material and negative, and was not addressed on the Q2 call.
  • Americas margin improvement remains promised but not shown; Q1 Americas adjusted EBITDA margin was flat at 19.4%.
  • Middle East is 7%–8% of sales, down double digits in Q2 with tripled logistics costs; rebuild timing is undated.
  • FY26 embeds $15M of transitory price/cost drag; if it extends, H2 margin recovery slips.
Bottom Line

Thesis is strengthening on execution but unproven on margins. The company delivered Eddyfi early, returned both segments to core organic growth, and crossed the 50% pro forma equipment threshold. Yet Q2 adjusted EBITDA margin fell 90 basis points, the adjusted EPS guide was cut, and the new asbestos ruling added an unquantified legal overhang. The open question is whether the promised margin expansion and Eddyfi accretion will show up in reported results over the next two quarters.

Next upThe next test is Q3 FY2026 organic growth, which management guided to be positive after Q2's +2.5%. H2 booked automation orders and price realization will show whether the 2%–4% organic guide holds.
Last Quarter — Q1 FY2026

Earnings Beat

Q2 FY2026 total sales were $766 million, up 13% year over year, with core organic growth of +2.5% in both segments. Adjusted EBITDA was $150 million, up 8% year over year, but adjusted EBITDA margin fell 90 basis points to 19.5%. Management attributed the margin decline to transitory price/cost neutrality and deliberate commercial investment in equipment growth.

MetricQ1 FY2026Q4 FY2025Q1 FY2025YoY
Revenue$746M$721M$678M+10.0%
Gross margin36.9%30.5%37.6%-70bps
EBITDA$137M$192M$127M+7.3%
EPS$0.78$0.62$1.11−29.8%
Core organic growth+2.5%-3.0% organic volume (Q1 FY26)n/aTurned positive
We closed the acquisition of Eddyfi ahead of schedule, a defining step that positions ESAB for faster organic growth and higher margins.— Shyam Kambeyanda, CEO, August 6, 2026

Management tone: Management remained confident and direct, but moved from explaining Q1's tariff-driven volume decline to asserting the strategic narrative on the Q2 call. Management emphasized the early Eddyfi close, the equipment mix crossing 50%, and the competitive claim that the combined joining-plus-inspection workflow is one only ESAB can provide.

Management Guidance

FY2026 guidance was reshaped on August 6. Management expects total core sales of approximately $3.0 billion to $3.1 billion, organic growth of 2% to 4%, acquisition contribution of approximately 9 points, and unchanged FX. Adjusted EBITDA was raised to $615 million to $625 million, including seven months of Eddyfi, while adjusted EPS was lowered to $5.40 to $5.50 on Eddyfi financing and share issuance. The guide embeds $15 million of transitory price/cost drag and assumes approximately 90% free cash flow conversion.

Business Trajectory

Trajectory

Reported revenue moved from $678.1 million in Q1 FY2025 to $745.6 million in Q1 FY2026, and Q2 FY2026 sales reached $766 million, up 13% year over year. Gross margin held at 36.9% in Q1 FY2026, while adjusted EBITDA margin was 18.3% in Q1 and 19.5% in Q2, with Q2 down 90 basis points year over year. The code-computed trajectory labels the revenue trend as decelerating, but Q2's +2.5% core organic growth after Q1's -3% volume supports management's H2 volume path; margin expansion still depends on price/cost normalization and equipment mix.

Revenue & Margin Trajectory
RevenueGross margin$0$250$500$750$568M$630M$606M$624M$648M$661M$620M$664M$684M$720M$681M$689M$690M$707M$673M$671M$678M$716M$728M$721M$746M35%37%Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26
RevenueGross margin$0$250$500$750$568M$630M$606M$624M$648M$661M$620M$664M$684M$720M$681M$689M$690M$707M$673M$671M$678M$716M$728M$721M$746M35%37%Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26
Gross margin as reported.
Share Price — 12 Months
$50$100$052-wk high $134Aug '25NovFeb '26MayAug '26
52-week range $84–$134.
Share Price — 12 Months
$50$100$052-wk high $134Aug '25NovFeb '26MayAug '26
52-week range $84–$134.
The Numbers

The Model

The model projects FY+1 revenue of $3,177 million and EBITDA of $629 million, an EBITDA margin of 19.8%. FY+2 revenue is $3,430 million with EBITDA of $731 million, a 21.3% margin. Near-term is anchored by Eddyfi's seven-month contribution to FY2026 and low-single-digit organic growth; FY+2 reflects the continued mix shift toward equipment and inspection, with the margin rate stepping above the FY+1 level.

Revenue & EBITDA Projections
REVENUE$2.8B$3.2B$3.4BFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN$576M$629M$731M21.3%FY25FY+1 (E)FY+2 (E)
REVENUE$2.8B$3.2B$3.4BFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN$576M$629M$731M21.3%FY25FY+1 (E)FY+2 (E)
Solid bars are reported actuals; outlined bars are model projections — not company guidance.
MetricFY2025Next FY (E)Following FY (E)
Revenue$2.8B$3.2B$3.4B
YoY Growth+11.8%+8.0%
EBITDA$576M$629M$731M
EBITDA Margin20.3%19.8%21.3%

Projections are the median of 5 independent model runs. The model’s revenue sits 8.4% above analyst consensus.

FY2026 guidance was reshaped on August 6. Management expects total core sales of approximately $3.0 billion to $3.1 billion, organic growth of 2% to 4%, acquisition contribution of approximately 9 points, and unchanged FX. Adjusted EBITDA was raised to $615 million to $625 million, including seven months of Eddyfi, while adjusted EPS was lowered to $5.40 to $5.50 on Eddyfi financing and share issuance. The guide embeds $15 million of transitory price/cost drag and assumes approximately 90% free cash flow conversion.

What Could Go Right — and Wrong

What good looks like
  • Eddyfi's ~$450 million commercial funnel converts into booked orders across nuclear, pipeline, rail, wind, and defense.
  • EWM turns EBITDA accretive in Q4 2026 and additive orders repeat with defense, distributor, and OEM customers.
  • Middle East stabilization returns a 7%–8% of sales region toward pre-conflict growth near 20%.
  • Semiconductor precision welding and gas-control demand becomes disclosed and meaningful.
  • Americas margin expansion arrives, supporting the path toward the company's gross-margin target above 40%.
What could go wrong
  • Asbestos liability is quantified and proves large.
  • Price/cost drag extends beyond the embedded $15 million FY26 assumption.
  • EWM is still dilutive after Q4 2026 or Eddyfi stays dilutive into 2027.
  • Europe demand proves to be tariff and carbon-tax pre-buy and reverses.
  • Middle East conflict persists, keeping 7%–8% of sales depressed with tripled logistics costs.
What’s Next

Looking Ahead

The next twelve months turn on execution: H2 automation shipments, Q3 and Q4 organic growth, and price progression are the near-term proofs. EWM is expected to turn EBITDA accretive as ESAB exits 2026, and Eddyfi is expected to become confidently positive in 2027. Management also targets consolidated gross margins above 40% for 2027 and beyond, with EU carbon-tax and tariff measures cited as local-manufacturing tailwinds. The May asbestos ruling remains an undated wildcard absent disclosure.

Catalysts
  • H2 2026Booked automation orders ship — Supports the 2%–4% organic guide; no dollar backlog disclosed.
  • Q3 2026Positive organic quarter — Management guided positive after Q2's +2.5% core organic growth.
  • Q4 2026EWM turns EBITDA accretive — Tests scheduled accretion as ESAB exits 2026.
  • Q4 2026Eddyfi contribution neutral — Expected slightly dilutive to neutral before the 2027 positive path.
  • Year-end 2026Leverage below 3x — Tests deleveraging after the Eddyfi close and ~90% FCF conversion.
  • 2027Eddyfi positive contribution — Expected to become confidently positive as ESAB enters 2027.
Numbers

Financials

Annual Summary

MetricFY2024FY2025TTMYoY
Revenue$2.7B$2.8B$2.9B+3.7%
Gross Margin37.9%35.6%35.4%227bps
EBITDA$514M$576M$2.5B+12.0%
EBITDA Margin18.8%20.3%20.1%+150bps
Net Income$265M$227M$207M-14.4%
Free Cash Flow$304M$213M$1.2B
Net Cash

Key Ratios (Trailing)

Valuation
  • P/E TTM
  • EV/EBITDA TTM
  • EV/Revenue TTM
  • Price/FCF TTM
Profitability
  • Gross Margin (TTM)35.4%
  • EBITDA Margin (TTM)20.1%
  • Net Margin (TTM)7.1%
  • ROIC11.5%
  • FCF Conversion37.3%
  • SBC / Revenue0.4%
Reference

The Company

ESAB Corporation describes itself as a focused premier industrial compounder providing fabrication technology, advanced equipment, consumables, gas control equipment, robotics, and digital solutions. It serves customers in approximately 150 countries and competes in a market it expects to be approximately $45 billion by the end of 2028. The central story is a deliberate portfolio shift from lower-margin consumables toward higher-margin equipment, gas control, and inspection through acquisitions including EWM, Bavaria, DeltaP, Aktiv, and Eddyfi.

As of December 31, 2025, ESAB had 4 production facilities in the United States and 33 outside the United States across 16 countries in Europe, Mexico, South America, the Middle East, India, and Southeast Asia. It operates through two reportable segments, Americas and EMEA & APAC, and runs a short-cycle business; the 10-Q describes unsatisfied performance obligations with an original contract duration over one year as immaterial. Management is reducing and optimizing the manufacturing footprint under the EBXai operating system.

Business Segments

Americas
Q2 FY2026 sales $316M, +12% y/y
North America led with double-digit organic equipment growth; Mexico stabilizing and South America still a headwind.
Growth driver: North America equipment and automation demand.
EMEA & APAC
Q2 FY2026 sales $450M, +14% y/y
Europe helped offset a double-digit Middle East decline; EWM integration remained on track.
Growth driver: Europe resilience and Middle East rebuild path.

Competitive Landscape

ESAB states in its 10-K that the markets it competes in are also served by Lincoln Electric and the welding business within Illinois Tool Works. Management's strategic claim is that the combined joining-plus-inspection workflow is one that only ESAB can provide. The source stack notes that neighbor transcripts supply contradictory caution on Europe durability, but no reviewed transcript mentioned ESAB by name.

  • Lincoln Electric
    Closest competitor per the 10-K. The source material does not quantify Lincoln Electric neighbor-call metrics; it only notes contradictory neighbor-transcript caution on Europe durability.
  • Illinois Tool Works (welding business)
    Named in the 10-K as a competitor; not discussed in the supplied call material.
Competitor set drawn from ESAB's 10-K; no quantified neighbor-transcript detail appears in the provided source material.

Supply Chain

ESAB sits in the fabricated-metal and industrial-infrastructure chain, selling welding consumables, equipment, gas control, and inspection. Documented relationships are thin; no neighbor transcript in the supply-chain scan mentioned ESAB by name.

Analysis updated Aug 12, 2026, reviewing Q1 FY2026. Prices delayed. Built with The Buildout’s published methodology. Not investment advice. No positions held. © The Buildout 2026.

More on ESAB: Earnings recap